Stay updated on Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The deletions remove sponsor attribution blocks for the study (H. Lee Moffitt Cancer Center and Research Institute) and the reference to the Moffitt Clinical Trials website, as well as the 'Helpful Links Provided by' label. This changes how attribution and related navigation are presented on the page.
    Difference
    0.2%
    Check dated 2026-05-29T22:55:44.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous v3.5.3 label. This indicates a backend/template update to the study record display without changing substantive study details.
    Difference
    0.1%
    Check dated 2026-05-15T15:13:25.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The page’s footer “Revision” version was updated from v3.5.2 to v3.5.3, reflecting a backend/site release rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:50:00.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.5.2 updated from v3.5.0. No visible changes to study details or page content.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:59.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Added the keyword/MeSH term 'B-cell chronic lymphocytic leukemia.' Added a new resource link to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T15:27:15.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.0, replacing v3.4.3. This is a UI/version change and does not alter study details or eligibility.
    Difference
    0.1%
    Check dated 2026-03-19T03:29:05.000Z thumbnail image

Stay in the know with updates to Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page.